• January 31, 2023

    Jubilant’s Radiopharma business receives NDA approval for Technetium Mertiatide Injection

  • September 22, 2021

    Eckert & Ziegler’s GalliaPharm®, exclusively distributed by Jubilant Radiopharma, approved for use with NETSPOT in Canada

  • 8 May 2021

    Jubilant Pharma wins over Bracco’s Legal Appeals in the United States Court of Appeals

  • 5 May 2021

    Jubilant Radiopharma and Cyclomedica Europe Announce Their Partnership for the Distribution of RUBY-FILL® During the International Conference on Nuclear Cardiology

  • 16 March 2021

    Jubilant Radiopharma and Isotopia Molecular Imaging Enter into a Strategic Partnership to Further Advance the Field of Radiotherapeutics

    Isotopia Molecular Imaging Limited (Isotopia) and Jubilant Radiopharma, a business division of Jubilant Pharma Limited, have entered into a strategic commercial partnership.

  • 4 November 2020

    Jubilant Radiopharma and SOFIE Biosciences Ink Strategic Partnership Deal to Further Advance the Field of Molecular Imaging & Therapeutics

  • 31 August 2020

    Eckert & Ziegler‘s GalliaPharm® to be distributed by Jubilant Radiopharma in Canada

  • 10 August 2020

    Jubilant Radiopharma and Navidea Biopharmaceuticals Sign Binding Memorandum of Understanding for Commercialization Partnership

We use cookies to recognize your repeat visits and preferences, as well as to measure the effectiveness
of campaigns and analyze traffic. If you continue to use this site we will assume your acceptance.